PD 113413
PD 113413 is formed by subsequent hydrolysis of the diketopiperazine quinapril analog. PD 113413 is a potent angiotensin-converting enzyme inhibitor. PD 113413 can be used for research of hypertension and congestive heart failure[1].
Product Specifications
CAS Number
[103733-50-2]
UNSPSC
12352005
Target
Angiotensin-converting Enzyme (ACE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/pd-113413.html
Solubility
10 mM in DMSO
Smiles
O=C1[C@@]2([H])N(C([C@H](C)N1[C@H](C(O)=O)CCC3=CC=CC=C3)=O)CC4=CC=CC=C4C2
Molecular Formula
C23H24N2O4
Molecular Weight
392.45
References & Citations
[1]Kaplan HR, et, al. Quinapril--a preclinical review of the pharmacology, pharmacokinetics, and toxicology. Angiology. 1989 Apr;40 (4 Pt 2) :335-50.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Pseudomonas fluorescens Transaldolase (tal)
Recombinant Pseudomonas fluorescens Transaldolase (tal)
Recombinant Pseudomonas fluorescens Transaldolase (tal)
Recombinant Pseudomonas fluorescens Transaldolase (tal)
Recombinant Pseudomonas fluorescens Transaldolase (tal)
